Hypnoanalgesia for Dermatological Surgery in Children
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04707014 |
|
Recruitment Status :
Completed
First Posted : January 13, 2021
Last Update Posted : January 13, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Anesthesia | Behavioral: Hypnosis Behavioral: Attention-distracting techniques | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 28 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Patients are randomly distributed to one of the following groups: Intervention group: Technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening. Control group: High-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure. |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Different investigators are assigned to each phase of the study, with one designated as responsible for recruitment (MQD), another for intervention and control (JMPP), and another for subsequent evaluation in the post-anaesthesia recovery unit (URPA) and at 24 hours (responsible nursing staff). |
| Primary Purpose: | Other |
| Official Title: | Effectiveness of Hypnoanalgesia for Dermatological Surgery in Children: Randomised Clinical Trial |
| Actual Study Start Date : | November 1, 2017 |
| Actual Primary Completion Date : | April 15, 2018 |
| Actual Study Completion Date : | April 30, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Placebo Comparator: Attention-Distraction techniques
A high-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.
|
Behavioral: Attention-distracting techniques
i-pad with movies, games and music |
|
Experimental: HIPNOSIS GROUP
A technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to the child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening.
|
Behavioral: Hypnosis
Rapid conversational hypnosis
Other Names:
|
- Total dose of propofol in mg/kg [ Time Frame: During surgery (Intra-operative) ]Measured in mg/kg weight
- Total dose of propofol in mg [ Time Frame: During surgery (Intra-operative) ]Measured in total mg
- Additional need for opioids during surgery [ Time Frame: During surgery (Intra-operative) ]Yes/no
- Pain intensity in older children post-operative [ Time Frame: Immediately post-operative while on recovery unit ]0-10 visual analogue scale (VAS) administered by a blinded nurse, with higher values indicating higher levels of pain
- Pain intensity in younger children post-operative [ Time Frame: Immediately post-operative while on recovery unit ]0-10 Faces Pain Scale - Revised (FPS-r) administered by a blinded nurse, with higher values indicating higher levels of pain
- Pain intensity in older children after 24 hours [ Time Frame: 24 hours after discharge ]0-10 visual analogue scale (VAS) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain
- Pain intensity in younger children after 24 hours [ Time Frame: 24 hours after discharge ]0-10 Faces Pain Scale - Revised (FPS-r) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain
- Analgesic need [ Time Frame: 24 hours after discharge ]Recorded by a blinded nurse at reanimation unit as yes/no
- Analgesic needs [ Time Frame: 24 hours after discharge ]Recorded by a blinded nurse by telephone call as yes/no
- Degree of satisfaction with the procedure [ Time Frame: 24 hours after discharge ]Validated survey with score 1-10 administered at the time of discharge to children and their guardians.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 5 Years to 16 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- A class I or II of anaesthetic risk according to the American Society of Anesthesiologists,
- to be in a percentile between P3 and P97 in weight and height,
- without known drug allergies, and
- having fasted 6 hours for solids and 2 hours for water.
Exclusion Criteria:
- Children with diagnosed mental retardation or attention deficit,
- behavioural disorders,
- previous treatment with hypnosis,
- history of neurological pathology or psychomotor retardation,
- previous pain-related pathology,
- obstructive sleep apnoea syndrome (OSAS)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04707014
| Spain | |
| Complejo Hospitalario Toledo | |
| Toledo, Spain, 45002 | |
| Principal Investigator: | Juana Maria PELAEZ PEREZ, PH | Complejo Hospitalario Toledo |
Documents provided by JUANA MARIA PELAEZ PEREZ, Complejo Hospitalario de Toledo:
| Responsible Party: | JUANA MARIA PELAEZ PEREZ, Anesthesiologist, Complejo Hospitalario de Toledo |
| ClinicalTrials.gov Identifier: | NCT04707014 |
| Other Study ID Numbers: |
CHT00028 |
| First Posted: | January 13, 2021 Key Record Dates |
| Last Update Posted: | January 13, 2021 |
| Last Verified: | January 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | Any document upon reasonable request to the PI. |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) |
| Time Frame: | Up to 1 year after publication |
| Access Criteria: | Justified interest in data. By e-mail to PI |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
analgesia anxiety pain paediatric surgery dermatology |
Hypnosis Nervous System Diseases Central Hypnotics and Sedatives Nervous System Depressants Physiological Effects of Drugs |

